SFDA To Disclose Government Information
This article was originally published in PharmAsia News
Executive Summary
China's State FDA will voluntarily disclose nine categories of government information including: organizational functions, personnel information, regulations and documents, announcements and notices, planning and programs, integration management, basic statistics, administrative permission and latest news. Citizens, legal entities and institutions may request such data from SFDA. Information such as quality bulletins, illegal drug advertisement notices, GMP and GSP authentication, adverse drug effects, tenders, key project approval and other details will be published at its website as well as via news conferences, newspapers, radio and TV to facilitate public access. The agency has officially started accepting such information requests since May 1. (Click here for more - Chinese Language)
You may also be interested in...
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.